At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic
germline genetic variant (hereditary cancer syndrome—HCS). These individuals are …

Objective This study explored motivators and challenges/barriers to sharing personal
genetic test results (GTR) with family members (FM). Methods Semi-structured, in-depth …

Rationale Men with BRCA-related cancer risks face increased disease risk as well as the
prospect of passing on their risk to children. Objective This study investigates men's …

Men with a germline pathogenic BRCA1 or BRCA2 variant have increased risks for
develo** breast, pancreatic, prostate, and melanoma cancers, but little is known about …

Family communication environments can be a facilitator or barrier to family cooperation and
communication in collecting family health history (FHH) information, which can facilitate …

Men with BRCA1 or BRCA2 gene mutations are at increased risk of develo** breast
cancer and may have an indication for breast cancer screening using mammography. Since …

BRCA1/2 germline mutations predispose carriers to an increased risk of breast, ovarian,
prostate, pancreatic, and skin cancer. Men and women are equally likely to pass on or …

Because of the rarity of male breast cancer (MBC) many men are unaware that the disease
exists. This leads both to delay in presentation and severe distress after diagnosis …

Little is known about how men and women who test positive for a BRCA gene mutation or
have a strong family history of carrying a BRCA mutation manage disclosures about their …

Identification of a hereditary prostate cancer in an affected individual can guide treatment
and may also impact cancer screening and surveillance for patients and their relatives. This …